If at First Tirzepatide Doesn’t Succeed, Keep Trying

NEW ORLEANS — When using tirzepatide (Zepbound, Eli Lilly) to treat obesity, patience may pay off.  New post hoc data from Lilly’s SURMOUNT-1 trial of people with overweight or obesity but not diabetes suggest that the drug will almost always produce at least 5% weight loss eventually, even among slow responders.  “Some obesity treatment guidelines…

Read More

Febuxostat Use Among Gout Patients Linked to Increased Cardiovascular Risk in new study

A recent study has found that the use of febuxostat among gout patients is associated with an increased risk of cardiovascular events. The study suggests that patients taking this medication should be monitored closely for potential cardiovascular complications. It is important for healthcare providers to consider this risk when prescribing febuxostat to patients with gout….

Read More

Unlocking the body’s defenses: Understanding immunotherapy

The human body’s immune system serves as a guardian against diseases by identifying and neutralizing threats like bacteria, viruses, and cancer cells. Scientists are using immunotherapy to enhance the body’s immune response to combat abnormal cells, such as cancer cells. Checkpoint inhibitors are a key component of immunotherapy, blocking molecules that cancer cells use to…

Read More

Europe Tightens Valproate Treatment Rules

The European Medicines Agency has recommended precautionary measures for the treatment of male patients with valproate after concerns about an increased risk of neurodevelopmental disorders in children fathered by men treated with the drug. The treatment should be started and supervised by a specialist and the potential risks explained to patients. Regular reviews of the…

Read More

Adjusting to Life With It

Idiopathic hypersomnia (IH) is a sleep disorder with no cure, causing excessive sleepiness. It can affect daily life and work or school performance. Treatment options may include medication, therapy, and lifestyle changes. People with IH may need more than 11 hours of sleep each night and may benefit from making sleep a priority. Behavioral therapy,…

Read More

New NCCN Melanoma Guidelines Capture Evolving Best Practice

The National Comprehensive Cancer Network (NCCN) has released new guidelines for cutaneous melanoma, which reflect the latest scientific evidence and consensus on best practices. These guidelines, chaired by Susan M. Swetter of Stanford University, highlight incremental advances in diagnosis and treatment, such as the recommendation for deep punch or elliptical biopsy following shave biopsies. The…

Read More
error: Content is protected !!